Shoulder Innovations (SI) Stock Price, News & Analysis

Company Overview

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams. The company collaborates with leading orthopedic specialists to refine surgical techniques, develop new implant geometries and conduct outcome studies. Its research and development efforts focus on advanced materials, biomechanical testing and minimally invasive procedures to improve implant longevity and patient recovery times.

Headquartered in the United States, Shoulder Innovations markets its products through a network of direct sales professionals and distribution partners to hospitals and surgical centers nationwide. The company is led by a management team with extensive experience in medical device development, regulatory affairs and orthopedic innovation. By investing in strategic partnerships and continuing education initiatives, Shoulder Innovations aims to drive growth and advance standards of care in shoulder reconstruction.

Key Stats

• Today's Range: $12.81 to $13.33
• 50-Day Range: $12.03 to $16.03
• 52-Week Range: $11.51 to $17.94
• Volume: 21,950 shs
• Average Volume: 160,885 shs
• Market Capitalization: $267.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $19.60
• Consensus Rating: Moderate Buy

Shoulder Innovations Stock Analysis - MarketRank™

Shoulder Innovations scored higher than 56% of companies evaluated by MarketBeat, and ranked 469th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Shoulder Innovations has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Shoulder Innovations has a consensus price target of $19.60, representing about 49.3% upside from its current price of $13.13.

Amount of Analyst Coverage

Shoulder Innovations has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Shoulder Innovations are expected to grow in the coming year, from ($0.56) to ($0.35) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Shoulder Innovations is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Shoulder Innovations is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.79% of the float of Shoulder Innovations has been sold short.

Short Interest Ratio / Days to Cover

Shoulder Innovations has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Shoulder Innovations has recently increased by 3.00%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Shoulder Innovations does not currently pay a dividend.

Dividend Growth

Shoulder Innovations does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.79% of the float of Shoulder Innovations has been sold short.

Short Interest Ratio / Days to Cover

Shoulder Innovations has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Shoulder Innovations has recently increased by 3.00%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for SI on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.

MarketBeat Follows

4 people have added Shoulder Innovations to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Shoulder Innovations insiders have bought more of their company's stock than they have sold. Specifically, they have bought $11,823,542.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.71% of the stock of Shoulder Innovations is held by insiders.

SI Stock Analysis - Frequently Asked Questions

How have SI shares performed this year?

Shoulder Innovations' stock was trading at $15.09 at the beginning of the year. Since then, SI shares have decreased by 13.0% and is now trading at $13.13.

How were Shoulder Innovations' earnings last quarter?

Shoulder Innovations, Inc. (NYSE:SI) released its quarterly earnings data on Monday, October, 18th. The company reported $0.88 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.17. The firm earned $51.71 million during the quarter, compared to analyst estimates of $45.19 million.

Does Shoulder Innovations have any subsidiaries?

Shoulder Innovations subsidiaries include Silvergate Bank, Silvergate Capital Trust I, Silvergate Capital Trust II, and Spring Valley Lots.

When did Shoulder Innovations IPO?

Shoulder Innovations (SI) raised $75 million in an initial public offering (IPO) on Thursday, July 31st 2025. The company issued 5,000,000 shares at $15.00 per share.

When did the company's quiet period expire?

Shoulder Innovations's quiet period expired on Tuesday, September 9th. Shoulder Innovations had issued 5,000,000 shares in its IPO on July 31st. The total size of the offering was $75,000,000 based on an initial share price of $15.00. During the company's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Shoulder Innovations?

Shares of SI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Shoulder Innovations own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Shoulder Innovations investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), PayPal (PYPL), Alibaba Group (BABA).

Company Calendar

• Last Earnings: 10/18/2021
• Today: 10/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:SI
• Previous Symbol: NYSE:SI
• CIK: 1699350
• Web: N/A
• Phone: 616-566-0286
• Fax: N/A
• Employees: 61
• Year Founded: 1988

Price Target and Rating

• Average Price Target for Shoulder Innovations: $19.60
• High Price Target: $23.00
• Low Price Target: $18.00
• Potential Upside/Downside: +50.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 20,360,000
• Free Float: 20,012,000
• Market Cap: $265.09 million
• Optionable: No Data
• Beta: N/A